Emmanouilides C E, Territo M
Department of Medicine, UCLA Center for the Health Sciences, Los Angeles, CA, USA.
Bone Marrow Transplant. 1999 Jul;24(2):205-6. doi: 10.1038/sj.bmt.1701864.
A 39-year-old polytransfused patient with aplastic anemia acquired transfusion-associated HTLV-I infection shortly before transplantation. The patient underwent allogeneic bone marrow transplantation and developed HTLV-I associated myelopathy 3 years later. Clinical abnormalities and a host of atypical findings are presented in the context of previous reports describing uncommon features of the disease.